- Home
- GH vs ENPH Comparison
GH vs ENPH Comparison
Compare GH & ENPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GH
- ENPH
- Stock Information
- Founded
- GH 2011
- ENPH 2006
- Country
- GH United States
- ENPH United States
- Employees
- GH N/A
- ENPH N/A
- Industry
- GH Medical Specialities
- ENPH Semiconductors
- Sector
- GH Health Care
- ENPH Technology
- Exchange
- GH Nasdaq
- ENPH Nasdaq
- Market Cap
- GH 4.9B
- ENPH 4.9B
- IPO Year
- GH 2018
- ENPH 2012
- Fundamental
- Price
- GH $98.28
- ENPH $32.97
- Analyst Decision
- GH Strong Buy
- ENPH Hold
- Analyst Count
- GH 22
- ENPH 27
- Target Price
- GH $74.32
- ENPH $47.20
- AVG Volume (30 Days)
- GH 3.4M
- ENPH 8.7M
- Earning Date
- GH 10-29-2025
- ENPH 10-28-2025
- Dividend Yield
- GH N/A
- ENPH N/A
- EPS Growth
- GH N/A
- ENPH 233.44
- EPS
- GH N/A
- ENPH 1.44
- Revenue
- GH $902,569,000.00
- ENPH $1,512,377,000.00
- Revenue This Year
- GH $33.95
- ENPH $13.35
- Revenue Next Year
- GH $25.77
- ENPH N/A
- P/E Ratio
- GH N/A
- ENPH $22.78
- Revenue Growth
- GH 30.38
- ENPH 20.97
- 52 Week Low
- GH $28.45
- ENPH $28.86
- 52 Week High
- GH $101.57
- ENPH $78.26
- Technical
- Relative Strength Index (RSI)
- GH 77.88
- ENPH 47.89
- Support Level
- GH $88.88
- ENPH $29.02
- Resistance Level
- GH $97.51
- ENPH $32.80
- Average True Range (ATR)
- GH 4.94
- ENPH 1.74
- MACD
- GH 1.89
- ENPH -0.17
- Stochastic Oscillator
- GH 88.05
- ENPH 49.14
About GH Guardant Health Inc.
Guardant Health, Inc, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company offers Guardant360 LDT, a liquid biopsy test for treatment selection in advanced stage cancer, Guardant360 CDx, an FDA-approved companion diagnostic for several targeted therapies, and Guardant OMNI, a broader gene panel for immuno-oncology research. In 2021, Guardant launched Reveal, a tumor-agnostic molecular residual disease, or MRD, test. In 2024, the company received US FDA approval for Shield, a liquid biopsy for colorectal cancer, or CRC, screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.
About ENPH Enphase Energy Inc.
Enphase Energy is a global energy technology company. It delivers smart, easy-to-use solutions that manage solar generation, storage, and communication on one platform. The company's microinverter technology primarily serves the rooftop solar market and produces a fully integrated solar-plus-storage solution. Enphase derives a majority of revenue from the United States.